» Articles » PMID: 12641614

Urine Biochemical Markers of Early Renal Dysfunction Are Associated with Iron Overload in Beta-thalassaemia

Overview
Specialty Hematology
Date 2003 Mar 19
PMID 12641614
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Renal dysfunction in thalassemia patients can be attributed to chronic anemia, and iron overload as well as to desferioxamine (DFO) toxicity. We analyzed the urine of 91 well-maintained homozygous beta-thalassemia patients, with no evidence of renal disease, for early evidence of kidney dysfunction by means of electrophoresis and quantitative biochemical tests. Measurement of liver magnetic resonance imaging (MRI) T2 values and serum ferritin concentration was used to estimate iron overload. In 55 of the 91 patients, urine analysis indicated signs of tubular dysfunction. The urine concentration of albumin and beta 2-microglobulin, as well as the activity of N-acetyl-beta-D-glucosaminidase (NAG), correlated positively with serum ferritin concentration and liver iron deposition, as detected by MRI T2 values. This suggested that the cause of renal dysfunction in homozygous beta-thalassemia is iron overload. On the other hand, the same urine markers did not correlate with age, indicating that chronic anemia or desferrioxamine (DFO) treatment are not related to renal dysfunction in thalassemia.

Citing Articles

Evaluation of iron overload in visceral organs in thalassemia patients by point shear-wave elastography.

Hattapoglu S, Cetincakmak M Ir J Med Sci. 2024; 193(5):2407-2412.

PMID: 38789665 DOI: 10.1007/s11845-024-03719-0.


Pattern and clinical correlates of renal iron deposition in adult beta-thalassemia major patients.

Meloni A, Barbuto L, Positano V, Pistoia L, Spasiano A, Casini T Clin Exp Med. 2023; 23(7):3573-3579.

PMID: 37433990 DOI: 10.1007/s10238-023-01133-x.


Clinical features and risk factors of renal dysfunctions in thalassemic patients.

Thongsaen P, Tonsawan P, Wanitpongpun C, Lanamtieng T, Phiphitaporn P, Teawtrakul N Int Urol Nephrol. 2023; 55(7):1779-1785.

PMID: 36749473 DOI: 10.1007/s11255-023-03506-3.


Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.

Aliberti L, Gagliardi I, Gamberini M, Ziggiotto A, Verrienti M, Carnevale A Br J Haematol. 2022; 198(5):903-911.

PMID: 35768889 PMC: 9542302. DOI: 10.1111/bjh.18345.


Renal function in β-thalassemia major patients treated with two different iron-chelation regimes.

Tanous O, Azulay Y, Halevy R, Dujovny T, Swartz N, Colodner R BMC Nephrol. 2021; 22(1):418.

PMID: 34930156 PMC: 8691002. DOI: 10.1186/s12882-021-02630-5.